Comparison of the genomic alterations present in tumor samples from patients with metastatic inflammatory versus non-inflammatory breast cancer reveals AURKA as a potential treatment target

Comparison of the genomic alterations present in tumor samples from patients with metastatic inflammatory versus non-inflammatory breast cancer reveals AURKA as a potential treatment target

Inflammatory breast cancer (IBC) is a rare but aggressive subtype of breast cancer, mainly characterized using primary tumor samples. Here, using public datasets, we compared the genomic alterations in primary and metastatic samples from patients with metastatic IBC versus patients with metastatic n...

Full description

Bibliographic Details
Main Authors: François Richard, Maxim De Schepper, Marion Maetens, Sophia Leduc, Edoardo Isnaldi, Tatjana Geukens, Karen Van Baelen, Ha-Linh Nguyen, Peter Vermeulen, Steven Van Laere, François Bertucci, Naoto Ueno, Luc Dirix, Giuseppe Floris, Elia Biganzoli, Christine Desmedt
Format: Article
Language:English
Published: Elsevier 2023-06-01
Series:Breast
Subjects:
Inflammatory breast cancer
Metastatic breast cancer
Genomic alterations
AURKA-Inhibitors
Online Access:http://www.sciencedirect.com/science/article/pii/S0960977623000103

Internet

http://www.sciencedirect.com/science/article/pii/S0960977623000103

Similar Items